Moving from the present to the future of Postural Tachycardia Syndrome - What we need
- PMID: 30539785
- PMCID: PMC6293980
- DOI: 10.1016/j.autneu.2018.06.007
Moving from the present to the future of Postural Tachycardia Syndrome - What we need
Abstract
Our understanding about Postural Tachycardia Syndrome (POTS) has advanced significantly over the last 25 years. Despite the significant advances that have been made in defining the syndrome and finding some treatments for our patients, there is much work to be done to significantly improve our understanding of the disorder and improve therapeutics. In this article, 5 NEEDS are identified that will be required over the next several years if we want future care to move beyond where we are in the present. These include: (1) a NEED for better administrative data to track POTS diagnoses and the impact of the illness; (2) a NEED to improve physician awareness about POTS, which is a prerequisite for improved access to care; (3) a NEED to better understand the multiple pathophysiologies underlying POTS and the roles of the different medical comorbidities; (4) a NEED for data on effective treatments for POTS; and (5) a NEED for more research funding to study POTS.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting - Part 2.Auton Neurosci. 2021 Nov;235:102836. doi: 10.1016/j.autneu.2021.102836. Epub 2021 Jun 30. Auton Neurosci. 2021. PMID: 34246578 Free PMC article.
-
Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance.Can J Cardiol. 2020 Mar;36(3):357-372. doi: 10.1016/j.cjca.2019.12.024. Can J Cardiol. 2020. PMID: 32145864
-
The patient perspective: What postural orthostatic tachycardia syndrome patients want physicians to know.Auton Neurosci. 2018 Dec;215:121-125. doi: 10.1016/j.autneu.2018.06.002. Epub 2018 Jun 7. Auton Neurosci. 2018. PMID: 29903594 Review.
-
Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management.Drugs. 2018 Jul;78(10):983-994. doi: 10.1007/s40265-018-0931-5. Drugs. 2018. PMID: 29943373 Review.
-
The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey.J Intern Med. 2019 Oct;286(4):438-448. doi: 10.1111/joim.12895. Epub 2019 Apr 16. J Intern Med. 2019. PMID: 30861229 Free PMC article.
Cited by
-
Non-invasive Vagus Nerve Simulation in Postural Orthostatic Tachycardia Syndrome.Arrhythm Electrophysiol Rev. 2023 Dec 13;12:e31. doi: 10.15420/aer.2023.20. eCollection 2023. Arrhythm Electrophysiol Rev. 2023. PMID: 38173801 Free PMC article. Review.
-
Whole-Blood MicroRNA Sequence Profiling and Identification of Specific miR-21 for Adolescents With Postural Tachycardia Syndrome.Front Neurosci. 2022 Jun 30;16:920477. doi: 10.3389/fnins.2022.920477. eCollection 2022. Front Neurosci. 2022. PMID: 35844239 Free PMC article.
-
Diagnosis and management of postural orthostatic tachycardia syndrome.CMAJ. 2022 Mar 14;194(10):E378-E385. doi: 10.1503/cmaj.211373. CMAJ. 2022. PMID: 35288409 Free PMC article. Review. No abstract available.
-
Ganglionic Acetylcholine Receptor Antibodies in Postural Tachycardia Syndrome.Neurol Clin Pract. 2021 Aug;11(4):e397-e401. doi: 10.1212/CPJ.0000000000001047. Neurol Clin Pract. 2021. PMID: 34484936 Free PMC article.
-
Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting - Part 2.Auton Neurosci. 2021 Nov;235:102836. doi: 10.1016/j.autneu.2021.102836. Epub 2021 Jun 30. Auton Neurosci. 2021. PMID: 34246578 Free PMC article.
References
-
- Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 1993. January;43(1):132–7. - PubMed
-
- Jacob G, Costa F, Shannon JR et al. The neuropathic postural tachycardia syndrome. N Engl J Med 2000. October 5;343(14):1008–14. - PubMed
-
- Shannon JR, Flattem NL, Jordan J et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 2000. February 24;342(8):541–9. - PubMed
-
- Raj SR, Biaggioni I, Yamhure PC et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation 2005. April 5;111(13):1574–82. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
